Optimal Antithrombotic Therapy in Ischemic Stroke Patients with Non-Valvular Atrial Fibrillation and Atherothrombosis
Phase 4
Terminated
- Conditions
- Ischemic StrokeAtherothrombosisAtrial Fibrillation
- Interventions
- Drug: Oral AnticoagulantDrug: Antiplatelet Drug
- First Posted Date
- 2017-02-23
- Last Posted Date
- 2024-12-27
- Target Recruit Count
- 321
- Registration Number
- NCT03062319
- Locations
- 🇯🇵
National Hospital Organization Osaka National Hospital, Osaka, Japan
© Copyright 2025. All Rights Reserved by MedPath